BRIEF-GSK stops lung cancer vaccine trial

LONDON, April 2 Wed Apr 2, 2014 2:17am EDT

LONDON, April 2 (Reuters) - GlaxoSmithKline

* Update on phase iii trial of mage-a3 antigen-specific cancer immunotherapeutic in non-small cell lung cancer

* Decision to stop magrit i trial

* Trial stopped after establishing not be possible to identify a sub-population of gene-signature positive nsclc patients that may benefit from treatment Source text for Eikon: Further company coverage:

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.